Concepts (118)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Recombination, Genetic | 2 | 2014 | 90 | 0.630 |
Why?
|
| Chromosomes, Bacterial | 1 | 2014 | 20 | 0.510 |
Why?
|
| Viral Envelope Proteins | 4 | 2009 | 77 | 0.510 |
Why?
|
| beta-Lactamases | 1 | 2014 | 33 | 0.510 |
Why?
|
| DNA Transposable Elements | 1 | 2014 | 44 | 0.500 |
Why?
|
| Acinetobacter baumannii | 1 | 2014 | 33 | 0.490 |
Why?
|
| Simian immunodeficiency virus | 3 | 2002 | 56 | 0.410 |
Why?
|
| Vaccines, DNA | 2 | 2009 | 23 | 0.380 |
Why?
|
| Antibodies, Viral | 3 | 2009 | 252 | 0.350 |
Why?
|
| Gastroenteritis | 2 | 2005 | 17 | 0.340 |
Why?
|
| Dengue Virus | 1 | 2009 | 84 | 0.330 |
Why?
|
| Genetic Vectors | 6 | 1996 | 154 | 0.290 |
Why?
|
| Rotavirus | 1 | 2005 | 11 | 0.270 |
Why?
|
| Feces | 1 | 2005 | 110 | 0.260 |
Why?
|
| SAIDS Vaccines | 2 | 2002 | 3 | 0.220 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 2002 | 4 | 0.210 |
Why?
|
| Clone Cells | 1 | 2002 | 46 | 0.210 |
Why?
|
| Virus Integration | 1 | 2002 | 49 | 0.210 |
Why?
|
| Lymphocytes | 1 | 2002 | 116 | 0.200 |
Why?
|
| Gene Products, env | 2 | 1996 | 23 | 0.180 |
Why?
|
| Receptors, Virus | 2 | 1996 | 20 | 0.170 |
Why?
|
| Molecular Sequence Data | 5 | 2014 | 1490 | 0.170 |
Why?
|
| Virus Replication | 2 | 1997 | 261 | 0.170 |
Why?
|
| Retroviridae | 2 | 1995 | 22 | 0.170 |
Why?
|
| Defective Viruses | 1 | 1997 | 10 | 0.160 |
Why?
|
| Cell Line | 6 | 2002 | 1289 | 0.160 |
Why?
|
| Gammaretrovirus | 1 | 1996 | 1 | 0.150 |
Why?
|
| Reticuloendotheliosis Viruses, Avian | 1 | 1996 | 1 | 0.140 |
Why?
|
| Point Mutation | 1 | 1996 | 88 | 0.140 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 3 | 2002 | 55 | 0.140 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 1996 | 41 | 0.140 |
Why?
|
| Reticuloendotheliosis virus | 1 | 1995 | 2 | 0.140 |
Why?
|
| Virus Assembly | 1 | 1995 | 38 | 0.130 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2014 | 84 | 0.130 |
Why?
|
| Acinetobacter Infections | 1 | 2014 | 22 | 0.130 |
Why?
|
| Evolution, Molecular | 1 | 2014 | 249 | 0.110 |
Why?
|
| Sequence Analysis, DNA | 1 | 2014 | 455 | 0.110 |
Why?
|
| Dogs | 4 | 1996 | 138 | 0.110 |
Why?
|
| Puerto Rico | 2 | 2014 | 1352 | 0.100 |
Why?
|
| Animals | 9 | 2009 | 14307 | 0.100 |
Why?
|
| Macaca mulatta | 2 | 2002 | 122 | 0.090 |
Why?
|
| Protein Sorting Signals | 4 | 1996 | 26 | 0.080 |
Why?
|
| Mice, Inbred BALB C | 1 | 2009 | 649 | 0.080 |
Why?
|
| Gene Expression | 3 | 1995 | 639 | 0.080 |
Why?
|
| Amino Acid Sequence | 4 | 1996 | 1124 | 0.070 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 1996 | 168 | 0.070 |
Why?
|
| Diarrhea | 1 | 2005 | 84 | 0.060 |
Why?
|
| Pilot Projects | 1 | 2005 | 628 | 0.060 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2002 | 17 | 0.060 |
Why?
|
| Transfection | 4 | 1996 | 496 | 0.060 |
Why?
|
| Interleukin-12 | 1 | 2002 | 46 | 0.050 |
Why?
|
| Humans | 6 | 2014 | 34853 | 0.050 |
Why?
|
| Peptides | 2 | 1995 | 308 | 0.050 |
Why?
|
| Proviruses | 1 | 2002 | 27 | 0.050 |
Why?
|
| Virion | 1 | 2002 | 67 | 0.050 |
Why?
|
| Plasmids | 3 | 1996 | 233 | 0.050 |
Why?
|
| Child | 2 | 2005 | 2875 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 3 | 1996 | 430 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 3 | 1995 | 286 | 0.050 |
Why?
|
| Mice | 2 | 2009 | 5668 | 0.050 |
Why?
|
| Osteosarcoma | 2 | 1996 | 24 | 0.040 |
Why?
|
| Flow Cytometry | 2 | 1996 | 392 | 0.040 |
Why?
|
| Adolescent | 2 | 2005 | 5035 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 2 | 1996 | 480 | 0.040 |
Why?
|
| Cell Membrane | 2 | 1996 | 360 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 1996 | 89 | 0.040 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1996 | 17 | 0.040 |
Why?
|
| Blotting, Southern | 1 | 1996 | 66 | 0.040 |
Why?
|
| Protein Folding | 1 | 1996 | 121 | 0.030 |
Why?
|
| Viral Core Proteins | 1 | 1995 | 10 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1996 | 162 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 1996 | 485 | 0.030 |
Why?
|
| Biological Transport | 1 | 1995 | 175 | 0.030 |
Why?
|
| Gene Targeting | 1 | 1994 | 39 | 0.030 |
Why?
|
| Middle Aged | 2 | 2005 | 9642 | 0.030 |
Why?
|
| Antibodies | 1 | 1994 | 135 | 0.030 |
Why?
|
| Research Design | 1 | 1996 | 292 | 0.030 |
Why?
|
| Adenoviridae | 1 | 1993 | 59 | 0.030 |
Why?
|
| Binding Sites | 1 | 1995 | 597 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 1997 | 1349 | 0.030 |
Why?
|
| Adult | 2 | 2005 | 11034 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 1995 | 486 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 3 | 1995 | 484 | 0.020 |
Why?
|
| Cloning, Molecular | 2 | 1995 | 310 | 0.020 |
Why?
|
| Inpatients | 1 | 2005 | 72 | 0.020 |
Why?
|
| Male | 2 | 2005 | 18870 | 0.020 |
Why?
|
| Base Sequence | 2 | 1995 | 932 | 0.010 |
Why?
|
| Hela Cells | 2 | 1994 | 344 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2002 | 145 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2005 | 871 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2002 | 217 | 0.010 |
Why?
|
| Adjuvants, Immunologic | 1 | 2002 | 106 | 0.010 |
Why?
|
| Survival Rate | 1 | 2002 | 310 | 0.010 |
Why?
|
| Infant | 1 | 2005 | 1014 | 0.010 |
Why?
|
| Viral Load | 1 | 2002 | 300 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2005 | 1318 | 0.010 |
Why?
|
| Disease Progression | 1 | 2002 | 580 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2005 | 2333 | 0.010 |
Why?
|
| Time Factors | 1 | 2002 | 1681 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2002 | 1300 | 0.010 |
Why?
|
| Codon, Terminator | 1 | 1995 | 12 | 0.010 |
Why?
|
| Cell Separation | 1 | 1995 | 91 | 0.010 |
Why?
|
| Dinitrophenols | 1 | 1994 | 6 | 0.010 |
Why?
|
| Leukemia Virus, Murine | 1 | 1994 | 3 | 0.010 |
Why?
|
| Binding Sites, Antibody | 1 | 1994 | 19 | 0.010 |
Why?
|
| CHO Cells | 1 | 1994 | 107 | 0.010 |
Why?
|
| Endoplasmic Reticulum | 1 | 1995 | 101 | 0.010 |
Why?
|
| Cricetinae | 1 | 1994 | 217 | 0.010 |
Why?
|
| Avian Sarcoma Viruses | 1 | 1993 | 3 | 0.010 |
Why?
|
| Ampicillin | 1 | 1993 | 5 | 0.010 |
Why?
|
| Moloney murine leukemia virus | 1 | 1993 | 7 | 0.010 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1993 | 22 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 1993 | 58 | 0.010 |
Why?
|
| Cytomegalovirus | 1 | 1993 | 38 | 0.010 |
Why?
|
| Aged | 1 | 2005 | 6448 | 0.010 |
Why?
|
| Drug Resistance | 1 | 1993 | 93 | 0.010 |
Why?
|
| DNA Replication | 1 | 1993 | 148 | 0.010 |
Why?
|
| Female | 1 | 2005 | 19873 | 0.000 |
Why?
|
Martinez- Martínez's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(118)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(2)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_